These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31290758)

  • 1. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
    Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
    Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal categorization in early oral tongue cancer.
    Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
    Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
    Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
    Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
    Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
    Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
    Almangush A; Leivo I; Mäkitie AA
    Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
    [No Abstract]   [Full Text] [Related]  

  • 7. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
    Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
    Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).
    Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Ghossein R; Patel SG; Katabi N
    Pathol Res Pract; 2021 Dec; 228():153473. PubMed ID: 34059347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
    Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.
    Chatzopoulos K; Sotiriou S; Collins AR; Kartsidis P; Schmitt AC; Chen X; Khazaie K; Hinni ML; Ramsower CA; Zarka MA; Patel SH; Garcia JJ
    Head Neck Pathol; 2021 Jun; 15(2):509-522. PubMed ID: 33010009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.
    Bjerkli IH; Hadler-Olsen E; Nginamau ES; Laurvik H; Søland TM; Costea DE; Uhlin-Hansen L; Steigen SE
    Virchows Arch; 2020 Dec; 477(6):865-872. PubMed ID: 32607687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
    Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
    Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
    Almangush A; Mäkitie AA; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Salo T; Leivo I
    BMC Cancer; 2020 Sep; 20(1):843. PubMed ID: 32883229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy quality is essential for preoperative prognostication in oral tongue cancer.
    Bello IO; Wennerstrand PM; Suleymanova I; Siponen M; Qannam A; Nieminen P; Leivo I; Almangush A; Salo T
    APMIS; 2021 Mar; 129(3):118-127. PubMed ID: 33320967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
    Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I
    Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma.
    Li J; Tang Y; Huang L; Yu Q; Hu G; Zou Y; Yuan X
    Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27868286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
    Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
    Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
    BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.